| Active substance | sotatercept |
| Holder | Merck Sharp & Dohme LLC, A subsidiary of Merck & Co. Inc |
| Status | Running |
| Indication | Adult patients with Pulmonary Arterial Hypertension (PAH) with WHO Functional Class (FC) II/III”. |
| Public documents | |
| Last update | 08/07/2025 |